PTSD Mobile App
PTSD Mobile App for Cancer Survivors
What will happen during the trial?
The purpose of this study is to use a stepped-care approach in treating symptoms of posttraumatic stress disorder (PTSD). The information learned by doing this study may help us to develop some target treatments for PTSD symptoms in survivors of stem cell transplant.
Participants in this study will be randomized to a mobile app or usual care. An assessment will be made after 4 weeks and a determination made of adding more intensive treatment. Participants will be asked to complete a questionnaire 4 times over a period of 6 months, at the time your participation is complete.
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Observational Trial
- Enrollment
- 400 patients (estimated)
- Sponsors
- Duke Cancer Center
- Tags
- Allogeneic Stem Cell Transplant, Autologous Stem Cell Transplant, Post-Allogeneic Stem Cell Transplant, Post-Autologous Stem Cell Transplant
- Trial Type
- Supportive
- Last Update
- 2 weeks ago
- SparkCures ID
- 1262
- NCT Identifier
- NCT04058795
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.